Investment Thesis
Linc invests in product-driven companies within the Nordic Life Science sector, focusing on early-stage pharmaceutical development and more mature medical technology ventures to drive improved quality of life.
Stage Focus
Early-stage (pharmaceuticals) and more mature (medical technology)
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Product-oriented companies in the Nordic Life Science industry, primarily pharmaceuticals and medical devices
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
N/A
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...